Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


The Impact of Clinical Trials in Tennessee


 
Sen. Mark Green, MD, discusses the importance of local clinical trials and biopharmaceutical research in Tennessee. Pictured (L-R) James and Josi Felts, Dr. Paul Newhouse, Dr. Jeffrey Conn, and Sen. Mark Green.

On Jan. 23, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report that finds there are more than 945 active clinical trials in the Tennessee. Additionally, the report said the life science industry supports 52,000 jobs and contributes $11.7 billion to the state's economy.

"Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in Tennessee," was released at an event held at the Cordell Hull Building, which featured a panel discussion by Vanderbilt University Medical Center biotech researchers, Tennessee State Senator Mark Green, MD, (R-22), and a local Alzheimer's disease patient and clinical trial participant.

"Clinical trials offer patients novel medical treatments while also allowing biopharma research organizations to innovate and grow," said Green, founder of Align MD. "Across the state - and particularly here in Nashville - the healthcare industry has had a profound impact on our economy."

In the United States, there are more than 7,000 open clinical trials being sponsored by the biopharmaceutical industry, universities, individuals and organizations. In Tennessee, active trials are studying treatment options for more than 20 disease sites or types, with cancer trials leading the way by a large margin. Of the 945 open clinical trials involving the biopharmaceutical research industry, Vanderbilt is collaborating on more than 245 of them. In addition, the report cites Meharry Medical College, Sarah Cannon, Clinical Research Associates, Tennessee Clinical Research Center, Tennessee Oncology, Tennessee Retina, and all of the city's major hospitals and health systems as active participants in Nashville.

"Many top universities call Tennessee home and are centers of innovation," said Jeffrey Conn, PhD, director of the Vanderbilt Center for Neuroscience Drug Discovery. "Maintaining strong partnerships between medical universities and life science companies allows us to foster developments right here in Tennessee that can then help save lives far beyond our state lines."

On average, it takes approximately a decade for new medicines to go through the FDA approval process, and only 12 percent of drugs successfully make it through clinical trials. Since 2004, biopharmaceutical research companies have conducted more than 6,100 clinical trials in Tennessee.

The complete report is available online at NashvilleMedicalNews.com

WEB:

Research in Your Backyard Report

 
Share:

Related Articles:


Recent Articles

Alexander: Bipartisan Legislation Will Lower What Americans Pay Out of Their Own Pockets for Health Care

The Lower Health Care Costs Act of 2019 contains nearly three dozen proposals from at least 16 Republican, 14 Democrat senators

Read More

If You Build It, They Will Come

Middle Tennessee's healthcare options continue to expand through new construction and facility renovations and additions.

Read More

Lease, Build, Buy, Sell: Finding the Best Fit for Each Medical Practice

When it comes to medical real estate, there is no one 'right' answer for every practice. Instead, experts say it's important to understand all the options before making a decision that impacts individual physicians, the practice ... and ultimately, patients.

Read More

Dr. Jerry Tannenbaum: Redefining, Redesigning Nephrology

Innovative building models and telemedicine mean better care for patients nationwide.

Read More

Wayfinding in Healthcare

With expansions, renovations and additions to healthcare facilities over time, the ability to easily navigate a campus is often lost along the way. Taking time to consider wayfinding can vastly improve the way patients, visitors and staff engage with the environment.

Read More

Building Walls

Steve Ward & Associates prefab headwalls mean more savings, options for healthcare clients.

Read More

LipiFlow®: Advanced Procedure to Treat Meibomian Gland Dysfunction & Chronic Dry Eye

In-office procedure can promote eyelid health and provide relief from dry eye.

Read More

SCALE 2019 Showcases Latest in Aesthetics Medicine

Now in its 14th year, the Music City SCALE Conference broke previous attendance records, with plans for additional growth in 2020.

Read More

Rethinking the Approach to Acne

New options and research have changed the traditional approach to treating acne.

Read More

Financing the Deal

Healthcare investment experts gathered for the Nashville Health Care Council's annual Financing the Deal panel focused on private equity trends and strategies.

Read More

Email Print
 
 

 

 


Tags:
Biopharmaceutical Research, Clinical Trials, Jeffrey Conn, Life Sciences, Mark Green, Pharmaceutical Research and Manufacturers of America, Pharmaceuticals, PhRMA, Research in Your Backyard, Vanderbilt
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: